These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. Lian EC; Mui PT; Siddiqui FA; Chiu AY; Chiu LL J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207 [TBL] [Abstract][Full Text] [Related]
31. [Prostacyclin stability in thrombotic thrombocytopenic purpura. Japan Working Group on TTP]. Koyama T; Kakishita E Nihon Rinsho; 1993 Jan; 51(1):142-5. PubMed ID: 8433507 [TBL] [Abstract][Full Text] [Related]
32. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623 [TBL] [Abstract][Full Text] [Related]
33. Analysis of clinical and laboratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China. Deng MY; Zhang GS; Zhang Y; Xiao H; Dai CW; Xu YX; Zheng WL; Peng HL; Shen JK Transfus Apher Sci; 2013 Dec; 49(3):447-52. PubMed ID: 23973730 [TBL] [Abstract][Full Text] [Related]
34. Carboxiterminal pro-endothelin-1 as an endothelial cell biomarker in thrombotic thrombocytopenic purpura. Mikes B; Sinkovits G; Farkas P; Csuka D; Rázsó K; Réti M; Radványi G; Demeter J; Prohászka Z Thromb Haemost; 2016 May; 115(5):1034-43. PubMed ID: 26763086 [TBL] [Abstract][Full Text] [Related]
36. Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011. Dahlan R; Sontrop JM; Li L; Ghadieh O; Clark WF Am J Nephrol; 2015; 41(6):429-37. PubMed ID: 26183258 [TBL] [Abstract][Full Text] [Related]
37. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Byrnes JJ; Moake JL Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932 [TBL] [Abstract][Full Text] [Related]
38. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission. Di Pasquale I; Budde U; Tona F; Bertomoro A; Lombardi AM; Famoso G; Bertozzi I; Dittmer R; Schneppenheim S; Fabris F Thromb Res; 2019 Jan; 173():42-47. PubMed ID: 30471507 [TBL] [Abstract][Full Text] [Related]
39. Studies of the pathogenesis and management of thrombotic thrombocytopenic purpura. Kakishita E; Nakajima T; Suehiro A; Koyama T; Ueda M; Tsujioka H; Yoshimoto H Pol J Pharmacol; 1996; 48(2):179-84. PubMed ID: 9112648 [TBL] [Abstract][Full Text] [Related]
40. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP). Kremer Hovinga JA; Studt JD; Lämmle B Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]